Influenza
Conditions
Interventions
None listed
Sponsors
National Institutes of Biomedical Innovation,Health and Nutrition
Axine Corporation(Australia)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: subjects whose serum is stored ,who consent to participate in this study
Exclusion criteria
Exclusion criteria: Not obtained the agreement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MicroRNA expression change in serum is measured by methods such as microRNA chip, a next-generation sequencer and qPCR. | — |
Countries
Japan,Australia
Contacts
Public ContactKen Ishii
National Institutes of Biomedical Innovation,Health and Nutrition Laboratory of Adjuvant Innovation
Outcome results
None listed